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INCREASING THE SUBSTRATE SPECIFICITY OF GEOBACILLUS 
STEAROTHERMOPHILUS LDH BY USING ITERATIVE SATURATION 
MUTAGENESIS 
SUMMARY 
 
Importance of chiral α-hydroxy acids (AHAs) are steadily increasing more in 
particular for the production of pharmaceutical and cosmetic dermatology. AHAs are 
indispensable for biotechology due to their importance in the production  
intermediate component for pharmaceutical industry. They are the main components 
of cosmetic-personal care product and also they have dermatological constructive 
effects. Chiral compounds are produced by using enzymes as biocatalyst in industrial 
biotechnological processes. However, enzymes are not stable under harsh conditions 
of the industry and recognizing a very small number of chemicals as substrate that 
has been limited the kemoenzimic production of industrially important chiral AHAs 
as a single enantiomer. Wild type Geobacillus stearothermophillus lactate 
dehydrogenase (bsLDH) can catalyze only the production of lactate from reduced 
chiral AHA. Therefore, enzyme engineering applications are needed for bsLDH 
which will recognize different chiral AHAs as substrate. In the proposed project, due 
to the high thermal resistance of bsLDH enzymes have been used. 
In this study, Iterative Saturation Mutagenesis (ISM)  was used in order to expand 
the substrate range of the enzyme. ISM, only focuses on amino acid position(s) of 
enzyme defined by experimental or computational studies functional or amino acid 
position(s) having potential of being functional.  Then, ISM forms mutant libraries 
which is limited with mutations based on candidate amino acid position(s). Due to 
targeting a few number of selected functional amino acids, formed mutant libraries 
by ISM are numerically much smaller than obtained libraries by directed mutations 
techniques. By selecting the best mutant from each mutant candidate library, ISM 
makes combinations for target mutant enzyme. Thus, ISM was repeated until 
obtaining the hit target enzyme. So ISM  reduces studies in the selection steps in a 
huge rate and makes much more possible to obtain mutants having the desired 
properties. 
In this project, we aimed to produce bsLDH for introducing different industrially 
important target AHA as a substrate. For this purpose six mutant libraries were 
designed in an effort to expand the substrate range of bsLDH. The eight variants 
were identified as having enhanced activity toward the selected α-keto acids 
(oxaloacetate, benzoylformate, phenylpyruvate), belongs to the same library. These 
new variants now may be useful biocatalysts for chiral synthesis of α-hydroxy acids. 
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TEKRARLAMALI DOYGUNLUK MUTAGENEZ YÖNTEMĠ ĠLE 
GEOBACILLUS STEAROTHERMOPHILUS LDH’IN SUBSTRAT 
ÖZGÜLLÜĞÜNÜN ARTIRILMASI 
ÖZET 
Hidroksi asitler (HA), yapılarında karbonil ve hidroksi gruplarını barındıran organik 
asitlerdir. Bu organik asitler; α-hidroksi asit (AHA), β-hidroksi asit (BHA), salisilik 
asit (SA) ve polihidroksi asit (PHA) olmak üzere dört (4) sınıfa ayrılır. Hidroksi 
asitlerin özellikle de AHA‟lerin endüstride kullanımı gün geçtikçe artmaktadır. 
AHA‟lerin dermatolojik olarak yapıcı etkilerinin olması, kozmetik-kişisel bakım 
ürünlerinin temel bileşenlerinden olması ve ilaç sanayisi için ara ürünlerin 
üretiminde kullanılmaları nedeniyle endüstriyel biyoteknoloji için vazgeçilmezdirler. 
AHA‟lerin üretimi için organik sentez kullanılan eski yöntemlerden biridir. Çünkü 
günümüz yeşil teknoloji devridir ve endüstriyel işlemlerde kullanılan kimyasalların 
yerini enzimler almış durumdadır. Kiral AHA‟ler, enzimlerin biyokataliz olarak 
kullanıldığı endüstriyel biyoteknolojik işlemlerle de elde edilirler. Biyokatalizörler 
kimyasal katalizörlerle kıyaslandığında; daha az maliyetli koşullarda farklı 
stereoselektif ve rejioselektif transformasyonları katalizleyebilmesi gibi avantajlar 
sağlamaktadır. Ancak, enzimlerin endüstrinin aşırı (asidik/bazik ve düşük/yüksek 
sıcaklık) koşullarına dayanıklı olmamaları ve çok az sayıda kimyasalı substrat olarak 
kabul etmeleri nedeniyle, endüstriyel öneme sahip kiral AHA‟lerin tek enantiomer 
olarak kemoenzimik üretimi çok sınırlı olmuştur. Enzimlerin bu dezavantajları 
yüzünden modifiye edilerek endüstride kullanıma uygun hale getirilmeleri 
gerekmektedir. Bu modifikasyonların gerçekleştirilmesi için protein mühendisliği 
tekniklerine ihtiyaç duyulmaktadır. 
Enzimler endüstriyel prosesler için modifiye edilirken; rasyonel tasarım (mantıklı 
tasarım/akılcı tasarım) metodu ile mutasyonlar tasarlanır. Ancak, ilgilenilen enzimle 
ilgili çok detaylı yapı bilgisi gerektirmesi, oluşturulacak yararlı mutasyon (lar) un 
belirlenmesi için uzun süreli çalışmalara ihtiyaç duyan deneysel-hesapsal bilgiler 
gerektirmesi bu metodun en büyük dezavantajları olarak sıralanmaktadır. Öte 
yandan, rekombinant deoksiribonükleik asit (DNA) teknolojisinin gelişmesiyle; 
mevcut rasyonel tasarım metoduna alternatif yeni metotlar geliştirilmiştir. En yaygın 
kullanılan metot ise ilgilenilen enzimde çeşitli tekniklerle (hata yapabilen (error-
prone) polimeraz zincir reaksiyonu (EP-PCR), karma DNA (DNA shuffling) gibi) 
rastgele mutasyonlar oluşturulması ve elde edilen içeriği 103-106 arasında olan mutant 
kütüphanesinden, istenilen özelliklere sahip mutant enzimlerin seçilmesi olarak 
uygulanan iki basamaklı yönlendirilmiş mutasyon teknolojisidir. Bu yöntemde 
ilgilenilen enzimin bütün amino asitlerinin hedef olarak seçilmesi ve mutasyonun bu 
amino asitler üzerinden rastgele oluşturulması nedeniyle anlamsız birçok mutantı 
içeren büyük bir mutant kütüphanesi elde edilmektedir. Bu kütüphane içerisinde, 
hedef olarak seçilen özelliklere sahip mutant enzimin seçilmesi için etkili, verimli ve 
kısa sürede sonuç verecek bir seçme tekniğine ihtiyaç duyulmaktadır. İstenilen 
özellikleri taşıyan mutant koloninin binlerce koloni içerisinden seçilebilmesi için; 
istenilen özellikleri taşıyan hedef mutant koloniye özgü bir seçme tekniğinin 
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olmayışı bu metodun en büyük dezavantajıdır. Ayrıca, sayıca çok büyük ve zengin 
mutant kombinasyonlarını içerecek bir kütüphane oluşturmak için uzun süreler 
gerektiren protokol iyileştirmelerine ve sonrasında seçme kısmında çok fazla 
laboratuvar çalışmasına/robotik teknolojilere ihtiyaç duyulmaktadır. 
Çalışmada, endüstriyel uygulamalarda AHA‟lerin üretimini sağlamak için termal 
dayanımı yüksek olması nedeniyle bsLDH enzimi kullanılmıştır. Yabanıl tip (WT) 
bsLDH, indirgenmiş kiral AHA‟lerden sadece laktatın üretilmesini katalizlemektedir. 
Piruvat ve laktat arasındaki reaksiyonu, NADH/NAD+ kofaktörlerini kullanarak 
katalizler. Reaksiyonu yüksek özgüllükte gerçekleştirir. Bu da endüstride kiral 
madde kullanımına ihtiyaç duyan alanlarda avantaj sağlayabilir. bsLDH‟ın termal 
dayanımının yüksek olmasına rağmen substrat aralığının dar olması bu enzimin 
kullanımı için bir dezavantaj oluşturmaktadır. Bu nedenle, farklı kiral AHA‟leri 
substrat olarak tanıyacak bsLDH için enzim mühendisliği uygulamalarına ihtiyaç 
duyulmaktadır.  
Bu çalışmada, enzimin substrat aralığının artırılması için alternatif protein 
mühendisliği yöntemi olan “Tekrarlamalı Doygunluk Mutagenez” (ISM) metodu 
kullanılmıştır. ISM, sadece deneysel ve hesapsal çalışmalarla daha önceden 
fonksiyonel olduğu belirlenmiş ya da fonksiyonel olma potansiyeline sahip az 
sayıdaki amino asit pozisyon (lar) ına odaklanır. Sonra aday amino asit pozisyon (lar) 
ı üzerinden sınırlandırılmış mutasyonlar içeren mutant kütüphaneleri oluşturulur. 
Sadece az sayıda fonksiyonel amino asit pozisyon (lar) ı hedef alması nedeniyle; 
oluşturulan mutant kütüphanesi, sayısal olarak yönlendirilmiş mutasyon teknikleri ile 
elde edilen kütüphanelere göre çok daha küçüktür. Her aday kütüphaneden en iyi 
mutantı seçerek, hedef mutant enzim için kombinasyon yapar. Aynı şekilde ISM en 
iyi hedef mutant enzim elde edilinceye kadar tekrarlanır. Dolayısıyla, ISM seçme 
basamağındaki çalışmaları büyük oranda azaltmakta ve istenilen özelliklere sahip 
mutantın elde edilmesini çok daha fazla mümkün kılmaktadır. Enzimlerin substrat 
aralığını genişletmek için; ISM metodu, kombine aktif bölge doyurulmuş test 
(CAST) tekniği ile (ISM/CAST) elde edilen bölgelere uygulanmaktadır. CAST 
rasyonel tasarım ve rastgele protein tasarım yöntemlerinin avantajlarını kullanarak; 
enzimin üç boyutlu (3D) yapı bilgisine (X-ışını yada homoloji modelleme 
yöntemiyle elde edilmiş) ve yapısıyla ilgili yapılmış çalışmalardan elde edilen 
bilgilere dayanarak; bağlanma bölgesine yakın bir yada daha fazla amino asit 
pozisyonundan oluşan bölgeleri belirler. İlgilenilen pozisyon ya da bölge, enzimin 
substrat tanımada etkili olduğu düşünülerek seçilir. Bu nedenle CAST tekniğinde 
doğru amino asit pozisyonlarını seçmek çok önemlidir. 
Tezin amacı, endüstriyel öneme sahip hedef kiral AHA‟leri substrat olarak 
kullanabilen yeni mutant bsLDH enzimini üretebilmektir. Bu nedenle, yeni 
biyokatalizörleri elde etmek için daha küçük ve fonksiyonel kütüphaneler kuran yarı 
rasyonel tasarım metodunun kullanılmasıyla bsLDH enziminin yeniden tasarlanması 
amaçlanmıştır. Bu çalışmada, altı (6) mutant kütüphanesi, bsLDH‟ın substrat 
çeşitliliğinin artırılması için oluşturulmuştur. Kütüphaneler oluşturulurken NRT 
dejenaratif kodon kullanılmıştır. Bu kodon 8 amino asidi (arjinin, asparajin, aspartik 
asit, sistein, glisin, histidin, serin, tirozin) kodlar. Kodlanan amino asitler ile 
oluşturulan kütüphaneler daha küçük ve zengin içeriğe sahiptir. Oluşturulan 
kütüphanelerin okzalasetat, fenilpiruvat, benzoilformata karşı taramaları yapılmış ve 
sekiz (8) LDH varyantı tanımlanmıştır. Bu varyantların hedef olarak seçilen α-keto 
asitlere (okzalasetat, fenilpiruvat, benzoilformat) karşı iyileştirilmiş aktiviteye sahip 
oldukları görülmüştür. Aktif mutantların kinetik karakterizasyonları, bsLDH‟ in 
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doğal substratı olan piruvat ve hedef substratlara karşı çalışılmış ve yabanıl tip 
bsLDH ile karşılaştırmaları yapılmıştır. Tüm bu çalışmalar sonunda, hedef 
substratlara karşı aktif olarak N101R102, D101Y102 ve N101C102 şeklinde 
isimlendirilen üç mutant elde edilmiştir. Okzalasetata karşı elde edilen N101R102 
mutantı, WT bsLDH ile karşılaştırıldığında kinetik parametreleri arasında çok fark 
olmadığı fakat mutantın az da olsa bir iyileştirme gösterdiği görülmüştür. Bir diğer 
mutant olan D101Y102‟ nin fenilpiruvata karşı ilgisi (KM) beş kat azalma 
gösterirken, turnover sayısında (kcat) beş kat artış görülmüş bunun sonucunda WT ile 
benzer kcat/KM oranına sahiptir. Benzoilformata karşı aktivite gösteren N101C102 
mutantının ise, WT ile karşılaştırıldığında kcat/KM oranının 2.5 kat daha aktif olduğu 
tespit edilmiştir. Literatür çalışmalarında benzoilformatı substrat olarak kullanan bir 
çalışma olmaması da bu mutantın önemini artırmıştır. Bu proje kapsamında elde 
edilmiş olan mutantların, kiral AHA‟ lerin biyoteknolojik olarak üretilmelerinde 
faydalı biyokatalizörler olabileceklerine inanılmaktadır.  
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1 
1.  INTRODUCTION 
1.1 Hydroxyl Acids 
Hydroxyl acid (HA) is an organic acid that includes at least one carboxy group. 
Hydroxy acids can be classified into four groups; alpha hydroxy acids (AHAs), beta 
hydroxy acids (BHAs), salicylic acid (SA) and poly hydroxy acids (PHAs) [1]. 
Figure 1.1 : Types of HAs; a) AHA, b) BHA, c) SA (salicylic acid), d) PHA 
(gluconolactone). 
1.1.1 Alpha hydroxy acid 
Alpha hydroxy acids (AHAs) represent a class of chemical compounds that are 
occurring naturally from many biological sources [2]. These carboxylic acids are 
substituted with a hydroxyl group on the adjacent carbon that can be named as α 
position [3]. 
1.1.1.1 Importance of AHAs 
Chirality has a significance role in drug discovery, food industry, cosmetic industry, 
chemistry and biological field. Chiral structures that are not superimposable on their 
mirror image have two enantiomers and living systems are consisted of chiral 
compounds [4]. Each enantiomer has a different effect, for example one stereoisomer 
can be active and provide therapeutic activity but the other can be inactive, toxic or 
harmful [5]. 
AHAs are important additives for cosmetic industry. It can remove the top layer of 
dead skin cells and ensure cellular renewal [6]. One proposed mechanism stated that 
calcium ions (Ca
+2
) are very important for skin and AHAs can reduce Ca
+2
 ions in 
a) b) c) d) 
2 
epidermis and it can induce cell growth and cell differentiation [7]. Use of these 
compounds may produce critical results depending on the dose. Skin can be more 
sensitive to ultraviolet light and this can increase the risk for skin cancer [8]. 
In organic synthesis, AHAs are valuable chiral building blocks. They can be useful 
for production of diversity of fine chemicals. For example, (R)-2-Chloromandelic 
acid is a main intermediate for an antidepressant and is an important precursor for 
synthesis of Clopidogrel [9]. They are also precursors for aldehydes synthesis [10, 
11]. 
Chemical and biotechnological processes have been developed for the synthesis of 
AHAs [12, 13]. Energy saving and low cost are advantages of biotechnological 
methods [15, 16]. Therefore, in recent years, studies are moving in biotechnological 
direction. Lactic acid, glycolic acid, phytic acid, mandelic acid, malic acid, 
phenyllactic acid can be given as examples of this group (Figure 1.2). 
Lactic acid is one of the most common AHA. It is naturally occurring from sour 
milk, glycolic acid is occurring from sugar cane, malic acid comes from apples [8]. 
They are generally used as therapeutic agents in many years to regenerate photo-aged 
skin. Glycolic acid has the smallest molecular size and it has the greatest 
bioavailability in cosmetic industry. These are helpful to reduce wrinkles, make skin 
smoother [16]. Phenyllactic acid can be used as an antiseptic agent and as a feed 
additive [17]. 
Figure 1.2 : Chemical structures of some AHAs a) Lactic acid, b) Glycolic acid, c) 
Mandelic acid, d) Phenyllactic acid e) Malic acid. 
 
a) 
d) 
c) b) 
e) 
3 
1.1.2 Beta hydroxy acid 
Beta hydroxyl acids (BHAs) are carboxylic acids with one hydroxyl group attached 
at the beta position of the carboxyl group. They are very similar to AHAs but they 
are lipid soluble compounds [1, 18]. 
β-hydroxybutanoic acid is the most common example of this group. It is polyester‟s 
precursor, which is a biodegradable plastic [19]. Tropic acid is a lipid soluble BHA 
that can be used in the synthesis of hyoscyamine and atropine [1, 20]. Malic acid and 
citric acid have hydroxyl groups that are in a position to one carboxyl group and the 
other one is in β position to other carboxyl group. Malic acid can be used as a flavor 
in the food industry and is an ingredient for cosmetic industry. Citric acid is alsofood 
additive and it can be used as an antioxidant [1, 21]. 
1.1.3 Salicylic acid 
Salicylic acid (SA) can be described as a BHA, but it is not necessarily true. It can 
also be described as a phenolic acid because hydroxyl group and carboxyl groups are 
linked to an aromatic benzene ring [22]. 
SA can be used as a food preservative. It is the  main component in skin-care 
industry and it can be used in order to produce pharmaceuticals like aspirin and 
sulpiride [23, 24]. 
1.1.4 Polyhydroxy acid 
Poly hydroxyl acids (PHAs) and polyhydroxy bionic acids (PHBAs) are new 
generation AHAs that include multiple hydroxyl groups bound to carbon atoms or 
alicyclic chain. PHBAs have an additional sugar molecule compared to PHAs. The 
effect nearly is the same as AHAs, but cause less irritation responses in skin-care 
industry [25]. 
The most known PHAs is gluconolactone that can protect skin against effects of 
ultraviolet radiation. The other PHA is lactobionic acid. They are also similar to 
AHAs, but they have larger molecule size when they compared to AHAs. They are 
also excellent components in dermatologic and cosmetic industry [26, 27].  
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1.2 Protein Engineering for Synthesis of AHAs 
Synthesis of optically pure AHAs is significant for many industries. Racemic 
mixtures that include both forms of compounds can be a trouble for the production of 
these compounds. In living systems, reactions can produce enantiomerically pure 
compounds and various natural products are enantiomerically pure due to use of 
enzymes as chiral catalysts. So several biocatalytic approaches can be applied for the 
production of AHAs [4]. 
Oxidoreductases (lactate dehydrogenase, hydroxy-isocaproate dehydrogenase, 
leucine dehydrogenase, mannitol dehydrogenase) are a class of enzymes that play a 
role in redox reactions. They catalyzereactions with high specificities (enantio- or 
region-) so they can play an important role in many industries which require chirally 
pure compounds [28, 29, 30]. 
In industrial processes, enzymes are needed to be modified in order to make them 
suited for processes. Extreme conditions like high temperature, acidic and basic pH 
conditions, salinity and limited substrate specificity are obstacles for the usage of 
enzymes. At this point protein engineering methods can be applied to enzymes in 
order to overcome these obstacles. 
Protein engineering is a multidisciplinary field and has many techniques and 
knowledge. The goals of protein engineering are to generate of novel molecules, to 
understand structure function relations and to design enzymes with desired properties 
(Figure 1.3) [31]. 
       WT Protein 
 
 
 
 
 
 
Figure 1.3 : Protein engineering flowchart. 
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Protein engineering approaches can be classified as “Rational design”, “Non-
Rational design” and “Semi Rational Design” [Figure 1.4]. 
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Figure 1.4 : Methods of protein engineering. 
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1.2.1 Rational design 
Rational design requires a detailed knowledge of protein; the amino acid sequence, 
three-dimensional (3D) structure and the relationship between structure and function 
in order to create improved and desired protein molecules. Homology modeling can 
be used to estimate the 3D structure of a protein in the absence of 3D structure. 
Therefore, suitable modeling studies can be useful to get 3D structure for many of 
proteins [33]. 
Site directed mutagenesis (SDM) is a classical and invaluable approach and is widely 
used in order to re-design a wild type protein with a new functionality. In this 
technique, mutations are created in one or more amino acids and the effects are 
evaluated [31, 34, 35]. Structure and function relationship can be investigated by 
using this technique. Key residues are changed with alanine in order to investigate 
the roles of active-site mechanism and understand which residues are responsible for 
substrate binding (it is known as alanine scanning) [36]. Using this technique, 
properties e.g. substrate specificity, coenzyme, increasing the thermostability of 
many enzymes can be developed [37, 38, 39, 40]. 
1.2.2 Directed evolution 
Directed evolution, also termed in vitro evolution, has been used since 1980s. This 
technique mimics natural evolution in the laboratory conditions. It does not require 
3D structure of the protein [41, 42].  
Directed evolution has two main steps; one is to create random libraries and second 
one is screening and selection of mutants with desired properties. This can be 
repeated until the desired degree of mutation is obtained [43]. 
Recombinative and non-recombinative methods can be classes of directed evolution. 
Non-recombinative method is random mutagenesis of the genes. It is a simple 
method to create diversity by making substitutions, insertions and deletions. Error 
Prone PCR can be example of this class. Recombinative method relies on gene 
fragments recombination which is homologous or non-homologous from different 
sources. DNA Shuffling and Family DNA Shuffling are given as examples of this 
class [35]. 
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1.2.3 Semi-rational design 
Rational design requires amino acid sequence and 3D structure and directed 
evolution‟s screening and selection steps are time consuming. Because of these 
limitations of  both methods, the new strategy namely semi-rational design has been 
developed. Semi-rational design is a combination of both rational design and directed 
evolution methods [44, 45]. 
Site saturation mutagenesis is an efficient method to improve enzyme properties. 
This method allows getting mutant libraries that include all possible amino acid 
changes with one or more desired target positions. Hence, the sequence is smaller 
than the other techniques; it can be screened rapidly [31]. 
1.2.4 Recent strategies: Iterative saturation mutagenesis and combinatorial 
active-site saturation test 
Iterative saturation mutagenesis (ISM) is a new, invaluable and efficient method in 
protein engineering. It is based on in vitro natural evolution process; library creation, 
screening and amplification. This strategy reduces screening efforts and it is possible 
to get high hit rate of mutants (Figure 1.5) [46]. 
This method is interested infunctional amino acid positions that are determined by 
experimental or computational studies. ISM only focuses on these positions and 
mutant libraries that are limited to these positions. Therefore, mutant libraries are 
much smaller than the other techniques. ISM method‟s mutations are provided from 
one initial library. ISM makes combinations and repeats until it obtains the hit target 
enzyme (Figure 1.6) [47]. 
 
 
 
 
 
Figure 1.5 :Schematic illustration of ISM [47]. 
ISM method is used for many practical applications and biotransformation [48, 49, 
50]. It can be used for increasing the enantioselectivity and for expanding substrate 
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specificity of the enzyme. For this purpose, combinatorial active-side saturation test 
(CASTing) can be applied. It was firstly applied on a lipase to expand substrate 
specificity [51]. CASTing is used at the active center of the enzyme as a reference 
and is focused around the binding pocket. Therefore, ISM/CASTing method creates 
effective and rich mutant libraries and also allows screening these libraries in less 
time [51]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 :Flow diagram of ISM [46]. 
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Codon usage is an important issue when applying ISM in order to randomize target 
amino acid positions (Table 1.1). Degeneracy usages reduce the necessary molecular 
biological work and screening effort and experimental work [47]. 
Table 1.1 : Commonly used degenerate codons. 
Degenerate 
Codon 
Number 
of codons 
Number of 
amino 
acids 
Number of  
stops 
Amino acids 
encoded 
NNK 32 20 1 All 20 
NDT 12 12 0 RNDCGHILFSYV 
DBK 18 12 0 ARCGILMFSTWV 
NRT 8 8 0 RNDCGHSY 
1.3 Geobacillus stearothermophilus L-Lactate Dehydrogenase (bsLDH) 
Geobacillus stearothermophilus L-Lactate Dehydrogenase (bsLDH) (EC 1.1.1.27) is 
a thermostable 2-hydroxy acid oxidoreductase that can catalyze the reaction between 
pyruvate (oxo acid) and lactate (hydroxyl acid) by using NADH/NAD
+
 pair (Figure 
1.7) [52]. 
 
 
 
 
Figure 1.7 :The reaction catalyzed by bsLDH. 
LDH is the most studied and well-known enzyme. The H form of the enzyme 
predominates in heart muscle and the L form of the enzyme predominates in skeletal 
muscle. These forms are combined differently and allow occurring of LDH 
isoenzymes [53]. LDH is regulated by fructose-1,6-bisphosphate and two molecules 
of fructose-1,6-bisphosphate bind per LDH [54]. 
LDH has two forms in nature, L-LDH (EC 1.1.1.27) and D-LDH (EC 1.1.1.28). 
Because of the different catalytic stereo specificity, it can be used for synthesis of 
chiral AHAs. LDH is a valuable biocatalyst due to their highest activity for pyruvic 
acid and  α ketonic acids [55]. The substrate specificity of  natural LDH can be 
Lactic acid Pyruvate 
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improved by altering the enzyme structure. At this point protein engineering can be 
applied to modify the enzyme [56]. 
First protein engineering study on bsLDH was the replacement of arginine to 
glutamine at 109
th
 position in 1986 [57]. Because this position is protected  in all 
LDH and it could play an important role  in substrate binding and hydride transfer in 
the reaction. This mutation has no effect on bsLDH due to the following alternative 
hydride transfer mechanism. In 1987, 171
st
 position at the active side of LDH was 
changed from Arg to Lys and this mutation allowedincrease in kcat and decrease in 
KM value [58, 59]. This mutant was applied in different substrates such as pyruvate, 
α-keto butyrate that have big side chains, KM value was decreased when the side 
chains were getting bigger. Therefore this position is important for forming enzyme-
substrate complex [59, 60]. Thr246Gly, Asp197Asn and Gln102Arg triple mutation 
in the enzyme  was lead to recognize oxaloacetate as substrate in 1987, but the 
catalytic activity was insufficient for industrial applications [60]. In 1988, alteration 
of the substrate specificity of bsLDH from pyruvate to malate was achieved by 
replacement of the glutamine residue by an arginine residue at 102
nd
 [61]. In 1989, 
Arg171 was changed with Thr and Tyr and different substrates were tried to increase 
catalytic activity [62].  To obtain succesful mutations, bsLDH reaction mechanism 
was modelled with improved computational techniques in 1991 [63]. In 1992, 109
th 
and 110
th
 positions that are located in mobile region werechanged and bsLDH 
recognized phenyllactate as a substrate [64]. In 1993, it was stated that Thr246 was 
responsible for hydride transfer due to no difference in kcat and KM values with the 
mutations [65]. In 1994 mutations at Gln102 with small amino acids like Ser, Thr 
lead to recognize different α keto acids as a substrates [66]. In 1996, first directed 
evolution method was applied on bsLDH and with cassette mutagenesis at 101
st
 and 
102
nd
 positions, bsLDH was screened towards to α-keto acids. Arg101Arg-
Gln102Val mutant recognized phenlypyruvate [55]. To get a mutant which shows the 
same activity without 1,6-FBP, directed evolution method was used for the first time 
for this purpose. It was achieved by mutations Arg118Cys, Glu203Leu, Asn307Ser 
but these mutants were not close to active site of the enzyme [67]. In 2001, to 
decrease substrate inhibition of bsLDH, Asp52 was changed with Glu  by using site-
directed mutagenesis but results were not enough for industrial applications [68]. In 
2009, malate specificity was gained by bsLDH by using DNA shuffling method [40]. 
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In 2013, LDH utilised L-mandelic acid as a substrate by using site-directed 
mutagenesis [69]. With the changes Ile240Ala and Thr246Gly, LDH recognized 
substrate that has aromatic side chain. 
1.4 The Aim of the Thesis 
bsLDH has high industrial potential because of its capability to produce highly 
enantiopure AHAs from pro-chiral α-ketoacids. As an effective biocatalyst, bsLDH 
can be employed for the synthesis of chiral AHAs, which are important for industrial 
applications. bsLDH has high thermal resistance but it has limited substrate 
specificity. 
Herein, we aimed to expand substrate specificity of bsLDH by using semi-rational 
engineering approach. 
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2.  MATERIALS and METHODS 
2.1 General Materials and Methods 
2.1.1 Plasmids, Strains and Media 
In this study, bsldh gene that was previously constructed in His-tagged pQE-2 
plasmid was used. 
Strains of Escherichia coli purchased from New England Biolabs (NEB-5α) and Life 
Technologies (BL21 Star (DE3)). 
Luria Bertani (LB) broth, Luria Borth - Agar Media (LB agar), Yeast Extract 
Tryptone (2x YT) and Auto Induction Media (AIM), which were used in protein 
expression experiment, were obtained from Formedium. Super optimal broth 
with catabolite repression (SOC) medium used for transformation was purchased 
from Invitrogen.  
2.1.2 Chemical Compounds and Laboratory Equipments 
Enzymes, chemical compounds and kits and laboratory equipments used in study 
were shown in Table 2.1, 2.2, 2.3. 
Table 2.1 : Enzymes. 
Enzyme Company 
Phusion HF DNA Polymerase BioLabs 
DpnI BioLabs 
DNaseI BioLabs 
Lysozyme Sigma 
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Table 2.2 : Chemical compounds and kits. 
Chemical compounds Company 
Ampicillin Formedium 
IPTG Formedium 
Tris-base Formedium 
Agarose Fischer Scientific 
Imidazole Sigma-Aldrich 
NaCl Fischer Chemicals 
NaH2PO4.2H2O Fischer Chemicals 
Glycerol Fischer Scientific 
Sodium pyruvate Fischer Scientific 
Oxaloacetate 96 % Acros Organic 
Phenylpyruvate 98 % Aldrich 
Benzylformate 97% Acros Organic 
Glycolic acid 99% Aldrich 
NADH Sigma 
Fructose 1,6-bisphosphate Sigma 
DNA ladder (1kb) BioLabs 
Protein ladder PageRuler Prestained 
Blue Loading Dye BioLabs 
Protein Stain Expedeon Instant Blue 
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Table 2.2 (continued): Chemical compounds and kits. 
Chemical compounds Company 
SDS-PAGE gels NuSep 
Protein Assay Kit 
Thermo ScientificTM 
PierceTM BCATM 
QIAprep Spin Miniprep Kit QIAGEN 
Table 2.3 : Laboratory equipments. 
Equipment Company 
pH Meter Hanna 
Heat Block VWR 
Rocker Stuart 
Biophotometer Eppendorf 
Static Incubator BINDER KT serie 
Orbital Shaker Incubator Infors HT Multitron Standart 
Microplate Reader Tecan 
Microfuge Thermoscientific 
Centrifuge Eppendorf  5810R, Beckman coulter 
Thermocycler Eppendorf  Mastercycler Gradient 
Electroporator BioRad 
Nanodrop Thermoscientific 
Sonicator MSE Soniprep 150 
Gel imaging Syngene 
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2.1.3 Transformations, starter cultures and glycerol stocks 
NEB-5α competent cells were used for mutagenesis, BL21 Star (DE3) competent 
cells were used for expression. Transformations into E.coli strains were performed 
by heat shock as below. 
 0.2 µl plasmid was added into chemically competent cells. 
 Plasmids into chemically competent cells were incubated 30 minutes on ice. 
 After 30 minutes, the tubes were placed in a water bath at 42oC for 30 
seconds and after that incubated on ice for 1-2 minutes. 
 200 µl pre-heated SOC medium was added into tubes and shaking vertically 
at 250 rpm, 37
o
C for 1 hour. 
 Plated on LB agar including 100 µg/ml ampicillin. 
 Plates were grown at 37oC overnight. 
For starter cultures, single colonies were picked from plates and inoculated in20 ml 
LB medium with ampicillin (100 µg/ml) in 50 ml sterile tubes. These cultures were 
grown at 37
o
C overnight with vigorous shaking at 225 rpm. 
Glycerol stocks were used for plasmid storage. 400 µl overnight cultures were mixed 
with 100 µl of 80% glycerol in 2 ml Eppendorf tubes. Tubes were shortly 
vortexedand stored at -80
o
C. Inoculating loop was used for scraping the frozen cells 
and then spread onto LB agar plate with ampicillin (100 µg/ml). 
2.1.4 Gel electrophoresis 
Agarose gel electrophoresis was carried out with Bio Rad equipment. Agarose gels 
were prepared with 0.50 mg agarose and 1 µl of SYBR Safe in 50 ml 1X TAE 
buffer. Gels were run at 90 V for 40 minutes to 1 hour. Bands were observed under 
UV.  
For SDS-PAGE, Tris-Glycine gels (NuSep) were used and was carried with Mini-
Protean gel tanks (Bio Rad). First, samples were boiled in Laemmli buffer for 10 
minutes at 95
o
C and were run 120 V for 35-45 minutes. Proteins were stained with 
InstantBlue Coomassie stain (Novexin). 
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2.2 Mutation Studies 
With ISM/CAST technique, functional or have a functional or potentially functional 
amino asit positions were determined. These positons were N101, Q102, R109, 
R171, H195, I240, T246. 
2.2.1 Plasmid isolation 
For this study, The QIAprep Spin Miniprep Kit was used for plasmid purification. 
 Bacterial cells which were grown 16 hours in LB medium with ampicillin 
(100 µg/ml) at 37oC, 225 rpm. were harvested. The supernatant was 
discarded. 
 Pellets were resuspended in 250 µl of Buffer P1. 
 250 µl of Buffer P2 was added and gently inverted 6 times. 
 350 µl of Buffer N3 was added and inverted immediately 6 times. 
 The solution was centrifuged at 13000 rpm for 10 minutes at room 
temperature. 
 The supernatant was transferred to QIAprep column and centrifuged 13000 
rpm for 1 minute to bind plasmid to high pure filter column. 
 After discarding the flow through, column was washed with 500 µl of Buffer 
PB and 750 µl of Buffer PE sequentially.  
 After washing step, column was placed in a clean 1.5 ml microfuge tube, then 
50 µl of binding buffer was added and waited for 10 min. 
 Centrifuged at 13000 rpm for 10 minutes and plasmid concentration was 
determined by using Nanodrop. 
2.2.2 PCR primers 
Primers were designed for mutagenesis in accordance with Stratagene QuikChange 
Protocol Primer Design. An NRT degenerative codon (N=A,T,C,G; R=A,G) was 
choosen torandomize candidate amino acid positions. 
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Primers were from Eurofins and the sequences were given in the table below. In the 
Table 2.4, F symbolizes forward and R symbolizes reverse. Red color shows 
degenerative codon in the related mutation positions. 
Table 2.4 : Primer sequences for mutagenesis. 
Primer Name Primer Sequence (5‟        3‟) 
N101Q102 F GCGCCGGCGCCNRTNRTAAACCGGGCG 
N101Q102 R CGCCCGGTTTAYNAYNGGCGCCGGCGC 
R109 F CCGGGCGAGACGNRTCTTGATCTTGTGG 
R109 R CCACAAGATCAAGAYNCGTCTCGCCCGG 
R171 F GGACGATTTTAGATACGGCGNRTTTCCGCTTTTTGTTGGGC 
R171 R GCCCAACAAAAAGCGGAAAYNCGCCGTATCTAAAATCGTCC 
H195 F GCCTATATTATTGGGGAANRTGGCGACACTGAACTCC 
H195 R GGAGTTCAGTGTCGCCAYNTTCCCCAATAATATAGGC 
I240 F GCCGCCTACCAAATTNRTGAGAAAAAAGGAGC 
I240 R GCTCCTTTTTTCTCAYNAATTTGGTAGGCGGC 
T246 F GAGAAAAAAGGAGCGNRTTACTACGGGATTGC 
T246 R GCAATCCCGTAGTAAYNCGCTCCTTTTTTCTC 
2.2.3 PCR profiles 
PCR was run using Eppendorf Mastercycler Gradient thermal cyclers. The thermal 
profiles and PCR reaction components were given in tables below. 
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Table 2.5 : PCR thermal profiles. 
Phase Step Temperature(
o
C) Time 
Initial Denaturation Denaturation 98
o
C 30 sec 
Amplification 
18 cycles 
Denaturation 98
o
C 30 sec 
Annealing 55
o
C 1 min 
Extension 72
o
C 2.5 min 
Final Extension Extension 72
o
C 5 min 
 Hold 4
o
C ∞ 
Table 2.6 : PCR reaction component. 
Reaction Component Volume (µl) 
Sterile dH2O 37.5 
5X Phusion HF Buffer 10 
10 mM dNTP mix 1 
DNA template (~60 ng) 0.5 
10 mM Primer mix 1 
Phusion DNA Polymerase 0.5 
 
After PCR, 2 µl DpnI was added to the PCR product and incubated for 3 hours at 
37
o
C to remove the original plasmid that was used as a template DNA. DpnI cuts 
only methylated DNA so that DpnI does not affect mutated plasmid, which is not 
methylated. 
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2.2.4 Transformation 
After DpnI digestion, plasmid was ready for transformation. For this purpose, heat 
shock procedure was used. 1 µl plasmid from DpnI digestion reaction was added to 
BL21 Star (DE3) competent cells and incubated on ice for 30 minutes. After the heat 
shock at 42
o
C for 30 sec., they were incubated on ice for  1-2 min. Then 200 µl SOC 
medium was added and bacteria were incubated vigorously shaking  at 37
o
C for 1 
hour. After 1 hour 100 µl from each transformation plated on LB agar plate with 
ampicillin (100 µg/ml) and was grown at 37oC overnight. 
2.3 Construction of Mutant Libraries 
For checking mutations, 1 ml LB was added to agar plate and mixed all colonies for 
each positions. Then The QIAprep Spin Miniprep Kit was used for plasmid 
purification. These mutant pool plasmids were sequenced at EuroFins Genomicsin 
order to check chromatogram results. Mutant pool plasmids were transformed to 
BL21 Star (DE3) and were grown at 37
o
C overnight. 
Colonies that were obtained from mutagesis were picked and transferred to 96 deep-
well plates containing 200 µl LB with ampicillin (100 µg/ml). Wild type bsLDH and 
empty vector were also transferred to wells as positive and negative controls. These 
deep-well plates were grown overnight at 37
o
C with shaking, at 250 rpm. These 
plates were named as “Master Plate” and stored in 20 % glycerol stocks at -80oC. 
 
Figure 2.1 : Image of plate for screening. 
2.4 Screening of Mutant Libraries 
Master plates were copied to 96 deep-well plates in 200 µl LB with ampicillin and 
were grown overnight at 37
o
C at 250 rpm for screening. Cells were harvested by 
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centrifugation at 4000 rpm for 20 min., medium was removed and the pellets were 
resuspended with lysis buffer that included 1mg/ml lysozyme and DNase in 50 mM 
Tris-HCl pH 7.4 buffer. After incubation at 30
o
C for 30 min the plates were 
centrifugated again at 4000 rpm for 20 min, the supernatants were screened for 
activity toward the NADH consumption at 340 nm (Figure 2.2). 
For screening, 96 well plates were used. 25 µl of supernant was transferred to 96 
well plates and then 75 µl reaction mix containing 1.33 mM NADH and 13.3 mM 
fructose-1,6-bisphosphate (1,6-FBP) in 50 mM Tris-HCl pH 7.4 buffer was added. 
After adding 20 mM target substrate (oxaloacetate, phenylpyruvate, benzylformate, 
glycolic acid), absorbance was immediately read and -NADH consumption was 
observed at 340 nm for 10 minute in a microplate reader. About 150 colonies were 
screened per library. Positive hits were rescreened again to validate activity. 
 
Figure 2.2 : The screening assay for detecting activity of bsLDH variants. 
2.5 Protein Expression of WT and Mutant bsLDHs 
WT bsLDH single colony was picked from the plate and inoculated into 20 ml LB 
with 100 µg/ml ampicillin and incubated overnight at 37oC at 250 rpm as a pre-
culture. Pre-cultures were grown in different expression conditions in order to 
understand which condition is the best for protein expression. These conditions had 
different mediums, different agitation speed and different temperatures. These 
conditions were given in Table below. 
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Table 2.7 : Different expression conditions. 
Medium Agitation speed 
(rpm) 
Temperature 
(
o
C) 
LB 250 16 
LB 250 20 
LB 250 25 
LB 250 37 
LB 200 37 
Auto-induction 250 20 
Auto-induction 200 25 
2X YT 250 37 
2X YT 200 37 
Pre-cultures were inoculated into 1 liter mediums with ampicillin (100 µg/ml) and 
incubated at 37
o
C and the OD600 was observed. When OD600 reached to 0.6, cultures 
were induced with 1 M isopropyl β-D-thiogalactoside (IPTG) (except Auto-Induction 
Media) with different temperatures and agitation speeds.  Before and after adding 
IPTG, 1 ml sample was taken and loaded to SDS-PAGE. According to SDS-PAGE 
results, best condition was choosen for protein expression (Auto-induction media, 
25
o
C, 200 rpm and 2 days incubation). 
Wt bsLDH and selected bsLDH mutants were grown in auto-induction media at 
25
o
C, 200 rpm for 2 days. Growing cells were harvested by centrifugation at 4500 
rpm at 4
o
C for 20 min. Pellets were resuspended with Buffer A (20 mM sodium-
phosphate, 500 mM NaCl, 30 mM imidazole, pH 7.4) with 1 mg/ml lysozyme and 
cells were placed on ice for 30 min. After incubation, cells were disrupted with 
sonication (20/20/20) and sonicated cells were collected by centrifugation at 22000 
rpm at 4
o
C for 30 min. Supernatant was used for purification. 
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2.6 Purification of WT and Mutant bsLDHs 
The clarified lysates were filtered through a 0.45 µm filter and purified by using Ni-
NTA His-Trap Column. First, column was washed with 10 ml water and was 
equilibrated with 5 ml Buffer A. The filtered samples were loaded onto column 
twice. Then column was washed with 5 ml Buffer A. After this step, bsLDHs were 
eluted with 3 ml of Buffer A with 100 mM imidazole, 5 ml of Buffer A with 200 mM 
imidazoleand 3 ml of Buffer A with 400 mM imidazole, respectively and collected as 
~ 1 ml fractions. These fractions were loaded to SDS-PAGE in order to control the 
purity of fractions. 
Protein concentration was determined with BCA method. Firstly, set of protein 
standarts were prepared from Bovine Serum Albumin Standart (BSA). Final BSA 
concentrations were 25, 125, 250, 500, 750, 1000, 1500, 2000 µg/ml. 25 µl standarts 
and samples were replicated into a 96 well-plate. 200 µl Working Reagent (WR) was 
added, mixed for 30 sec. and incubated at 37
o
C for 30 min. After incubation, plate 
was cooled to room temperature and absorbance was measured at 562 nm absorbance 
on a microplate reader. 
2.7 Enzyme Activity Assay 
First, the specific activity was determined by monitoring the absorbance changes at 
340 nm due to catalyzed redox reactions for wild-type and mutant LDHs. The 
purified enzyme (10 µl) was transferred to 96 well-plate. After that, 90 µl reaction 
mix (1.11mM NADH, 11.1 mM 1,6-FBP in 50 mM pH 7.4 Tris-HCl) was mixed 
with enzyme and the reaction was started by 100 µl 20 mM target substrates 
(benzoylformate, oxaloacetate, phenylpyruvate, pyruvate). Best mutant bsLDHs were 
determined for their target substrate in accordance with specific activity results. 
The steady-state kinetic experiments were done for wild type and best mutant 
bsLDHs. Reaction mixture was contained 1.11mM NADH, 11.1 mM 1,6-FBP, 
different concentrations of target substrate and enzyme in 50 mM pH 7.4 Tris-HCl. 
The rates were determined at 340 nm by absorbance change due to NADH 
consumption and fitted using the GraFit. Experimantal work was summarized in 
Figure 2.3. 
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Figure 2.3 : Summary of experimental study. 
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3.  RESULTS AND DISCUSSION 
3.1 Mutagenesis Amplification 
In order to expand substrate specificity of bsLDH, mutant library was constructed by 
mutagenesis according to Stratagene Quik Change protocol (Quik Change II Site-
Directed Mutagenesis Kit) using Phusion polymerase, reaction buffer, dNTPs and 
designed primers. Six mutant libraries were constructed (N101Q102, R109, R171, 
H195, I240, T246). The amplified PCR products were run and controlled in agarose 
gel electrophoresis as shown in Figure 3.1.  
 
 
 
 
 
 
Figure 3.1 :Images of PCR products. M; Marker 1 kb DNA ladder (Biolabs); 10 kb, 
8 kb, 6 kb, 5 kb, 4 kb, 3 kb, 2 kb, 1.5 kb, 1 kb, 0.5 kb., A(R109), B(R171), C(H195), 
D(I240), E(T246) and F(N101Q102) are PCR products that are mutated regions. 
3.2 Transformation 
The amplified PCR products that had amino acid changes at determined sites were 
transformed into BL21(DE3) competent cells. With transformations, many colonies 
were obtained for mutated regions at desired mutation sites (Figure 3.2). 
 
 
M     A    B    C 
M  D  E  F M  A    B    C  
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Figure 3.2 : Images of libraries; a) N101Q102, b) I240, c) R171, d) R109, e) H195, 
f) T246. 
a) b) 
c) 
e) f) 
d) 
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3.3 Mutation Confirmation 
In each position, all colonies were mixed and collected into together. Plasmid 
purification was done and these mutant pool plasmids were sent to sequence against 
to pQE (5‟CCCGAAAAGTGCCACCTG„3). Sequence chromatogram results of 
mutant pool plasmids showed that desired positions were encoded by NRT 
degenerative codon.  In the Table 3.3 showed that A, G, C, T densities at determined 
positions. 
a) 
 
b) 
 
c) 
 
Figure 3.3 : Sequence chromatogram result of libraries; a) N101Q102, b) R109, c) 
R171, d) H195, e) I240, f) T246. 
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d) 
 
e) 
 
f)  
 
Figure 3.3 (continued) : Sequence chromatogram result of libraries; a) N101Q102, 
b) R109, c) R171, d) H195, e) I240, f) T246. 
3.4 Screening of Mutant Libraries 
Replica plates were screened for each position by following NADH consumption at 
340 nm. In total, approximately 800 colonies were screened over the six libraries. 
Eight positive hits showed enhanced activity toward benzoylformate (1C3), 
oxaloacetate (2D4) and phenylpyruvate (1G7, 1F2, 1A2, 1H4, 2B3 and 1D12) 
compared to wild-type bsLDH. All eight variants came from the same library 
targeting position (N101Q102). The residue identities for positions 101 and 102 of 
these eight clones are provided in Table 3.1. 
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Table 3.1 : The amino acid mutations of bsLDH variants. 
Substrate Variants Position101 Position102 
Pyruvate WT Asn Gln 
Benzoylformate WT Asn Gln 
 1C3 Asn Cys 
Oxaloacetate WT Asn Gln 
 2D4 Asn Arg 
Phenylpyruvate WT Asn Gln 
 1G7 Asp Tyr 
 1F2 Cys Asp 
 1A2 Asn Asp 
 1H4 Asp His 
 2B3 Gly Asp 
 1D12 Ser Asp 
3.5 Protein Purification 
For protein expression, different conditons were tried. Samples were collected before 
and after IPTG induction. Pellets and supernatants were run on SDS-PAGE (NuSTep 
gel) for each conditions (Figure 3.4).  
 
Figure 3.4 : SDS-PAGE images for different expression conditions. M; Marker 
PageRuler Prestained Protein Ladder (Thermo Scientific); 170 kDa, 130 kDA, 100 kDa, 70 
kDa, 55 kDa, 40 kDa, 35 kDa, 25 kDa, 15kDa, 10kDa. A) Using BugBuster: 1-Before IPTG 
(16
o
C) 2-After  IPTG Supernatant (16
o
C) 3-After IPTG Pellet (16
o
C) 4- Before IPTG (20
o
C) 
5- After  IPTG Supernatant (20
o
C) 6- After IPTG Pellet (20
o
C) 7- Before IPTG (25
o
C) 8- 
After  IPTG Supernatant (25
o
C) 9- After IPTG Pellet (25
o
C) 10- Before IPTG (37
o
C)11- 
After  IPTG Supernatant (37
o
C)12- After IPTG Pellet (37
o
C). B) After sonication: 1-
Supernatant (16
o
C)  2-Pellet (16
o
C) 3- Supernatant (20
o
C) 4- Pellet (20
o
C)  5- Supernatant 
(25
o
C) 6- Pellet (25
o
C)   7- Supernatant (37
o
C) 8- Pellet(37
o
C) C) After sonication: 1-
Supernatant 20
o
C 250 rpm auto induction media 2-Pellet 20
o
C 250 rpm auto induction media 
3- Supernatant 25
o
C 200 rpm auto induction media 4- Pellet 25
o
C 200 rpm auto induction 
media 5- Supernatant 37
o
C 250 rpm LB 6- Pellet 37
o
C 250 rpm LB  7- Supernatant 37
o
C 250 
rpm 2X YT 8-Pellet 37
o
C 250 rpm 2X YT 9- Supernatant 37
o
C 250 rpm non induced LB 10- 
Pellet 37
o
C 250 rpm non induced LB 11- Supernatant 37
o
C non induced 2X YT 12-Pellet 
37
o
C non induced 2X YT. 
WT and the eight variants showing improved activity were individually grown in 
auto-induction media (25
o
C, 200 rpm, 2 days). Protein purification was done by 
70kDa 
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using Ni-NTA His-Trap column and the collected fractions were analyzed by SDS-
PAGE. 
a)       b) 
 
Figure 3.5 : SDS-PAGE images of pure active bsLDH variants. M; Marker PageRuler 
Plus Prestained Protein Ladder (Thermo Scientific); 250 kDa, 130 kDA, 100 kDa, 70 kDa, 
55 kDa, 35 kDa, 25 kDa, 15kDa, 10kDa. a) 1-WT 2- N101C102 3- WT 4-N101R102 b) 1-
N101D102 2-C101D102 3- S101D102 4- G101D102 5- D101Y102 6- D101H102. 
3.6 Kinetic Activity Results 
Specific activities of positive hits calculated against 10 mM their target substrates. 
Specific activities of each variants for the respective new substrate are listed in Table 
3.2. 
Table 3.2: Specific activity results of positive hits. 
Substrate Residue at 
Position 
101 
Residue at 
Position 
102 
Specific activity 
(µmol/min.mg) 
Pyruvate Asn Gln 48.88 ± 1.87 
Benzoylformate Asn Gln 7.11 ± 0.98 
 Asn Cys 10.98 ± 1.62 
Oxaloacetate Asn Gln 23.87 ± 3.52 
 Asn Arg 27.55 ± 1.50 
Phenylpyruvate Asn Gln 7.39 ± 0.75 
 Asp Tyr 51.26 ± 3.35 
 Cys Asp 30.01 ± 1.24 
 Asn Asp 28.71 ± 2.13 
 Asp His 24.91 ± 2.05 
 Gly Asp 22.60 ± 0.85 
 Ser Asp 21.63 ± 1.95 
LDH variants 1C3 (N101C102), 2D4 (N101R102), 1G7 (D101Y102) exhibited the 
highest activity for benzoylformate, oxaloacetate and phenylpyruvate, respectively, 
and appeared to be the most improved for these non-natural substrates. These three 
70kDa 
25 kDa 
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LDH variants were also assayed against a range of concentrations of pyruvate and 
the respective screening substrate to determine steady state kinetic parameters and 
corresponding activity changes compared to the WT enzyme for the natural and 
respective non-natural substrate. 
The 1C3 variant with a Gln102Cys mutation showed approximately 2.5 fold increase 
in catalytic efficiency over the wild type enzyme for the novel substrate 
benzoylformate in addition to a significant loss in pyruvate activity primarily due to a 
4.5- fold reduction in kcat. The 2D4 variant did not provide any improvement in 
oxaloacetate activity, but rather only a reduction in activity on the natural substrate, 
yielding a 7-fold loss in catalytic efficiency towards pyruvate. The 1G7 variant 
evolved for activity on phenylpyruvate showed a surprisingly 4.5-fold increase in 
kcat;  however, an equivalent reduction in KM result in the variant having the same 
catalytic efficiency as the wild type enzyme. In all cases, the LDH variants showed 
significant loss in activity for the natural substrate, pyruvate, despite it is not being 
an aspect of the screening process. A comparison of the substrate specificity of each 
LDH variant through catalytic efficiencies for the natural and non-natural substrates 
highlights the large change in the activity caused by these mutations. As shown in 
Table 3.4, each of the new LDH variants has greater activity for the target substrates 
(ratio of less than 1), indicating that the enzymes are more active on the non-natural 
substrates than on pyruvate. 
Table 3.3 : The substrate specifity of each variant. 
Substrates bsLDH variants 
(kcat/KM) natural / 
(kcat/KM) non-
natural 
Pyruvate / 
Benzoylformate 
WT (N101, Q102) 14.893 
1C3 (N101, C102) 0.558 
Pyruvate / 
Oxaloacetate 
WT (N101, Q102) 1.800 
2D4 (N101, R102) 0.206 
Pyruvate / 
Phenylpyruvate 
WT (N101, Q102) 8.120 
1G7 (D101, Y102) 0.466 
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Table 3.4 : Kinetic parameters for bsLDH variants 
bsLDH 
variants 
Substrates 
Pyruvate Benzoylformate 
KM 
(mM) 
kcat 
(s
-1
 ) 
kcat/KM 
(mM
-1
s
-1
) 
KM 
 (mM) 
kcat 
(s
-1
 ) 
kcat/KM 
( mM
-1
s
-1
) 
WT  
(N101, 
Q102) 
0.25 
±0.04 
25.8 
±0.9 
104.55 
0.44 
±0.11 
3.08 
±0.17 
7.02 
1C3 
(N101, 
C102) 
0.58 
±0.10 
5.79 
±0.23 
9.90 
0.29 
±0.06 
5.23 
±0.19 
17.74 
 
Pyruvate Oxaloacetate 
WT  
(N101, 
Q102) 
0.25 
±0.04 
25.8 
±0.9 
104.55 
0.25 
±0.04 
14.58 
±0.44 
58.12 
2D4 
(N101, 
R102) 
0.35 
±0.07 
5.18 
±0.21 
14.95 
0.21 
±0.04 
14.99 
±0.44 
72.47 
 
Pyruvate Phenylpyruvate 
WT  
(N101, 
Q102) 
0.25 
±0.04 
25.8 
±0.9 
104.55 
0.44 
±0.10 
7.54 
±0.37 
17.31 
1G7 
(D101, 
Y102) 
0.61 
±0.08 
3.81 
±0.12 
6.27 
2.43 
±0.35 
35.34 
±1.30 
14.49 
 
a) 
Benzoylformate    Mandelic acid 
b) 
 
Oxaloacetate     Malic acid 
Figure 3.6 :The reactions catalyzed by active bsLDH variants a) N101C102, b) 
N101R102, c) D101Y102. 
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c) 
 
Phenylpyruvate     Phenyllactic acid 
Figure 3.6 (continued) :The reactions catalyzed by active bsLDH variants a) 
N101C102, b) N101R102, c) D101Y102. 
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4.  CONCLUSIONS 
LDH provides reversible conversion between an α-keto acid (pyruvate) and an α-
hydroxy acid (lactate), by using NADH/NAD
+
 as cofactor. bsLDH is extremely 
enticing to engineer for producing different chiral α-hydroxy acids which can be used 
in manufacturing pharmaceutical intermediates. Since the experimental 
determination of the structure of bsLDH, several enzyme engineering studies in the 
last 25 years have targeted different amino acid positions for increasing bsLDH 
substrate specificity. Rational design and directed evolution techniques have so far 
been tried for this purpose, focusing on residues N101, Q102, R109, R171, H195, 
I240 and T246 of bsLDH to clarify the roles of these residues in substrate binding 
and catalytic mechanism. Despite this, engineered bsLDH variant still remain fairly 
limited in differing substrate specificity. 
In this study, a semi-rational design method was applied to bsLDH. The semi-
rational design can be a more productive method for constructing a smart and small 
library of interesting biocatalysts since the potential variation is more selectively 
chosen as a smaller subset of amino acids. Selection of the right candidate amino 
acid positions is extremely important to the success of this method. The NRT 
degenerative codon chosen in this work only encodes eight amino acids, all of which 
have small or charged side chains. This was intentionally chosen to accommodate 
larger α-keto acid target substrates within the active site of bsLDH without disrupting 
crucial orientation with the catalytic residues. In addition, NRT considerably reduces 
the library size needed for screening >95% of all possible combinations of amino 
acids incorporated at each position, down to 24 variants rather than the 96 required 
for screening an NNK degenerate codon library. 
A screening method was previously developed on solid phase for screening bsLDH 
libraries on α-hydroxy acids. This screen is based on colorimetric detection of redox 
catalysis via a reaction between dyes and NADH produced by variants able to 
oxidize target α-hydroxy acids. However, during the application of this method for 
our LDH construct, colonies were not adequately disrupted and sufficient protein 
was not available to provide a clear colour change to indicate activity. The new 
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screening method used in this work was carried out for the generated libraries using 
the target α-keto acids as substrate and  screening in the reduction direction. The 
lysis buffer and lysozyme applied for cell disruption released sufficient protein to 
directly screen the cell lysate. Although this method is lower throughput than the 
solid phase screen, it was still sufficient for screening the focused NRT libraries, and 
also proved to be more sensitive than the solid phase screen.  
Screening identified eight variants that showed higher activity toward the non-natural 
substrates benzoylformate, oxaloacetate, or phenylpyruvate. Interestingly, all variants 
with enhanced activity were from one  library, targeting positions 101 and 102. The 
obtained experimental results support the previously characterized functions of 
R109, R171, H195, I240 and T246 as critical for orienting the substrates (including 
NADH) and catalyzing the reduction of the α-keto acid substrate. The specific 
activities of these purified variants were measured and revealed a high level of 
activity on the non-natural substrates. Three different variants (1C3, 2D4 and 1G7, 
one for each non-natural substrate) were selected as the best performing enzymes, 
and steady-state kinetic parameters were determined with the respective screening 
substrates and pyruvate, revealing that each new variant had altered specificity in 
favour of the non-natural α-keto acid over pyruvate. 
To date, there has not been any reported bsLDH activity on benzoylformate. In this 
study, the selected 1C3 bsLDH variant showed 17.74 mM
-1
s
-1
 as catalytic efficiency, 
a notable 2.5-fold improvement against benzoylformate from the wild type enzyme, 
giving a potential biocatalytic route to S-mandelic acid. The Gln102Cys mutation 
also resulted in an about 10.5-fold decrease in catalytic efficiency for pyruvate. 
Replacing Gln with Cys in position 102 removes the steric hindrance that likely 
prevents benzoylformate from binding effectively. Based on molecular modelling 
studies, the mutation appears to increase the volume of the substrate binding pocket 
to accommodate the phenyl ring of the new substrate in the active site, while still 
maintaining the appropriate interactions with catalytic residues.The combination of 
these significantly improves the kinetic parameters for benzoylformate, creating a 
bsLDH variant that is more efficient for benzoylformate than for pyruvate, but still 
active on both substrates. 
The 2D4 LDH variant with Gln102Arg mutation exhibits essentially the same 
activity as wild type LDH toward oxaloacetate, but does provide about a 7-fold 
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decrease in pyruvate catalytic efficiency. These results are consistent with the role 
already reported for residues at positions 101 and 102 (55), however the more 
improved Asn101Arg/Gln102Arg variant they identified was not detected in our 
screen. Although the substitution of Gln102Arg increases the size of the residue, the 
positively charged Arg side chain presumably provides a more beneficial interaction 
with the carboxylate of oxaloacetate than the polar Gln side chain in the wild type 
enzyme. 
A similar increase in specific activity toward phenylpyruvate was observed for the 
six identified variants. The highest improvement of specific activity was identified 
for variant 1G7 with Asn101Asp and Gln102Tyr mutations. In this variant, kcat was 
increased approximately 5-fold for against phenylpyruvate. However, due to a 5-fold 
loss in KM, the catalytic efficiency of this variant is the same as the wild type 
enzyme. Similar to the effect of the mutation in variant 1C3, these two mutations are 
expected to provide the increased active site volume required to bind the large 
phenylpyruvate substrate. These results of the series of six improved enzymes give 
more perspective for analysing substrate recognition and its accommodation by the 
active site pocket of bsLDH. In spite of the vastly different amino acids observed in 
positions 101 and 102, these six variants are all more effective than wild type against 
phenylpyruvate, which suggests that there is a sizeable range of functional sequence 
variation permitted at these positions. The acceptance of residues with small, polar, 
aromatic, positively charged or negatively charged side chains at positions 101 and 
102 indicates that bsLDH variants can possibly be engineered to accept a diverse 
array of functionalized α-keto acid substrates that may allow access to a large series 
of substrates for production of other industrially relevant α-hydroxy acids. 
In conclusion, creating pure chiral α-hydroxy acids as building block intermediates is 
so valuable due to the functional properties they can impart on pharmaceutical 
chemicals. We have identified three variants of bsLDH with significantly enhanced 
activity towards the selected α-keto acids to produce chiral α-hydroxy acids. The 
measured KM and kcat of three novel biocatalysts support that the catalytic efficiency 
achieved in bsLDH is fairly comparable with those resulting from similar efforts on 
bsLDH in the past, however a smaller and more focused library screen was used in 
the present study. 
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In further studied, the generated libraries can be screened against different target 
substrates in order to produce different α-hydroxy acids. In addition to this, different 
protein engineering approaches can be applied and compared to this study. 
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APPENDIX A : Screening Results 
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Figure A.1 : Screening results. 
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g)              h) 
 
 
 
 
 
 
 
 
 
Figure A.1 (continued) : Screening results. 
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APPENDIX B: Michaelis-Menten graphics of WT and mutant bsLDH 
 
 
 
 
 
 
Figure B.1 : Michaelis-Menten graphics. 
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Figure B.1 (continued) : Michaelis-Menten graphics. 
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APPENDIX C: Amino acids and their 1-Letter and 3 Letter codes. 
Table C.1:Amino acids and their 1-Letter and 3-Letter codes. 
Amino Acid 1-Letter 
Code 
3-Letter 
Code 
Alanine A Ala 
Arginine R Arg 
Asparagine N Asn 
Aspartate D Asp 
Cysteine C Cys 
Glutamate E Glu 
Glutamine Q Gln 
Glycine G Gly 
Histidine H His 
Isoleucine I Ile 
Leucine L Leu 
Lysine K Lys 
Methionine M Met 
Phenylalanine F Phe 
Proline P Pro 
Serine S Ser 
Threonine T Thr 
Trytophan W Trp 
Tyrosine Y Tyr 
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